US20020041847A1 - Immunotherapy of malignant and autoimmune disorders in domestic animals using naked antibodies, immunoconjugates and fusion proteins - Google Patents

Immunotherapy of malignant and autoimmune disorders in domestic animals using naked antibodies, immunoconjugates and fusion proteins Download PDF

Info

Publication number
US20020041847A1
US20020041847A1 US09/921,290 US92129001A US2002041847A1 US 20020041847 A1 US20020041847 A1 US 20020041847A1 US 92129001 A US92129001 A US 92129001A US 2002041847 A1 US2002041847 A1 US 2002041847A1
Authority
US
United States
Prior art keywords
cell
method
antibody
antibodies
antibody component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/921,290
Inventor
David Goldenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/038,995 priority Critical patent/US6134982A/en
Priority to US09/307,816 priority patent/US6306393B1/en
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Priority to US09/921,290 priority patent/US20020041847A1/en
Assigned to IMMUNOMEDICS, INC. reassignment IMMUNOMEDICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOLDENBERG, DAVID M.
Publication of US20020041847A1 publication Critical patent/US20020041847A1/en
Application status is Abandoned legal-status Critical

Links